Evidence map›Paper›PMID 32728107›Full record

ArticleEuropean journal of human genetics : EJHG2020

Accurate fetal variant calling in the presence of maternal cell contamination.

Elena Nabieva, Satyarth Mishra Sharma, Yermek Kapushev, Sofya K Garushyants, Anna V Fedotova, Viktoria N Moskalenko, Tatyana E Serebrenikova, Eugene Glazyrina, Ilya V Kanivets, Denis V Pyankov and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Elena Nabieva *Skolkovo Institute of Science and Technology, Skolkovo, Russia. e.nabieva@skoltech.ru.ORCID http://orcid.org/0000-0002-4532-6085
Satyarth Mishra Sharma *Skolkovo Institute of Science and Technology, Skolkovo, Russia.
Yermek KapushevSkolkovo Institute of Science and Technology, Skolkovo, Russia.
Sofya K GarushyantsSkolkovo Institute of Science and Technology, Skolkovo, Russia.
Anna V FedotovaSkolkovo Institute of Science and Technology, Skolkovo, Russia.
Viktoria N MoskalenkoLomonosov Moscow State University, Moscow, Russia.
Tatyana E SerebrenikovaProgen LLC, Moscow, Russia.
Eugene GlazyrinaProgen LLC, Moscow, Russia.
Ilya V KanivetsGenomed LLC, Moscow, Russia.ORCID http://orcid.org/0000-0001-5821-9783
Denis V PyankovGenomed LLC, Moscow, Russia.ORCID http://orcid.org/0000-0003-2519-4908
Tatyana V NeretinaInstitute for Information Transmission Problems (Kharkevich Institute), Russian Academy of Sciences, Moscow, Russia.
Maria D LogachevaSkolkovo Institute of Science and Technology, Skolkovo, Russia.
Georgii A BazykinSkolkovo Institute of Science and Technology, Skolkovo, Russia.ORCID http://orcid.org/0000-0003-2334-2751
Dmitry YarotskySkolkovo Institute of Science and Technology, Skolkovo, Russia.
Skolkovo Institute of Science and Technology · RULomonosov Moscow State University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-throughput sequencing of fetal DNA is a promising and increasingly common method for the discovery of all (or all coding) genetic variants in the fetus, either as part of prenatal screening or diagnosis, or for genetic diagnosis of spontaneous abortions. In many cases, the fetal DNA (from chorionic villi, amniotic fluid, or abortive tissue) can be contaminated with maternal cells, resulting in the mixture of fetal and maternal DNA. This maternal cell contamination (MCC) undermines the assumption, made by traditional variant callers, that each allele in a heterozygous site is covered, on average, by 50% of the reads, and therefore can lead to erroneous genotype calls. We present a panel of methods for reducing the genotyping error in the presence of MCC. All methods start with the output of GATK HaplotypeCaller on the sequencing data for the (contaminated) fetal sample and both of its parents, and additionally rely on information about the MCC fraction (which itself is readily estimated from the high-throughput sequencing data). The first of these methods uses a Bayesian probabilistic model to correct the fetal genotype calls produced by MCC-unaware HaplotypeCaller. The other two methods "learn" the genotype-correction model from examples. We use simulated contaminated fetal data to train and test the models. Using the test sets, we show that all three methods lead to substantially improved accuracy when compared with the original MCC-unaware HaplotypeCaller calls. We then apply the best-performing method to three chorionic villus samples from spontaneously terminated pregnancies.

Indexed as

DNA ContaminationAdultBayes TheoremChorionic Villi SamplingFemaleGenetic TestingHumansMachine LearningMutationPregnancySequence Analysis, DNASignal-To-Noise Ratio

Identifiers

PMID32728107
PMCPMC7576216
OpenAlexW3045557397

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.